Empagliflozin
JARDIANCE
Sodium-Glucose Cotransporter 2 Inhibitor
NADAC/unit
$11.1962
No Shortage
Tier 1: 35.9%
SYNJARDY SYNJARDY is a combination of empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor and metformin hydrochloride (HCl) immediate-release, a biguanide, indicated as an adjunct to....
vs. brand JARDIANCE: Generic saves up to -12% per unit
Market Intelligence
2024-01-03 Class II Recall: CARDINAL HEALTHCARE
2023-03-29 Class II Recall: Boehringer Ingelheim Pharmaceuticals, Inc.
Generic Manufacturers
BOEHRINGER INGELHEIM PHARMACEUTICALS INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.